Coherus Biosciences reported $-80925000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Aerie Pharmaceuticals AERI:US $ -33643000 85.38M
Akebia Therapeutics AKBA:US $ -58493000 7.66M
ALKERMES ALKS:US -26585000 28.97M
Alnylam Pharmaceuticals ALNY:US $ -146732000 47.83M
Amarin AMRN:US -28307000 44.04M
Amgen AMGN:US $ 2500M 196M
Baxter International BAX:US $ 531M 108M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Bluebird Bio BLUE:US $ -120346000 138.95M
Bristol Myers Squibb BMY:US $ 3188M 399M
Coherus Biosciences CHRS:US $ -80925000 41.38M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Endo International Ordinary Shares ENDP:US $ 120.25M 52.02M
Fujifilm 4901:JP 43.25B 35.34B
Gilead Sciences GILD:US $ 2897M 1957M
Horizon Pharma HZNP:US 196.44M 99.18M
Ironwood Pharmaceuticals IRWD:US $ 57.85M 1.25M
JAZZ PHA JAZZ:US 87.55M 105.43M
LG Chem 051910:KS 1024.26B 275.84B
Merk MRK:US $ 5059M 207M
Myriad Genetics MYGN:US $ -14900000 33.8M
Pacira Pharmaceuticals PCRX:US $ 21.73M 24.09M
Perrigo Ordinary Shares PRGO:US $ 23.1M 39.7M
Pfizer PFE:US $ 9995M 4136M
Ptc Therapeutics PTCT:US $ -86522000 1.79M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M
Revance Therapeutics RVNC:US $ -62221000 617K
Sarepta Therapeutics SRPT:US $ -86881000 18.93M
Teva Pharmaceutical TEVA:IT 789M 182M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M
Xencor XNCR:US $ 26.47M 65.19M
Zoetis ZTS:US $ 794M 197M